WallStreetZenWallStreetZen

NASDAQ: AKBA
Akebia Therapeutics Inc Stock Ownership - Who owns Akebia Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Akebia Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
John P. ButlerCEO and President2026-03-0469,270$1.25
$86.59kBuy
Steven Keith BurkeSVP Chief Medical Officer2026-02-0225,375$1.39
$35.27kSell
Steven Keith BurkeSVP Chief Medical Officer2026-02-0220,701$1.39
$28.77kSell
John P. ButlerCEO and President2026-02-0246,660$1.39
$64.86kSell
John P. ButlerCEO and President2026-02-0296,065$1.39
$133.53kSell
John P. ButlerCEO and President2026-02-02114,891$1.39
$159.70kSell
John P. ButlerCEO and President2026-02-02175,250$1.41
$247.10kBuy
John P. ButlerCEO and President2026-02-0283,689$1.39
$116.33kSell
Nicholas GrundChief Commercial Officer2026-02-0253,585$1.39
$74.48kSell
Nicholas GrundChief Commercial Officer2026-02-0231,244$1.39
$43.43kSell

1 of 3

AKBA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AKBA insiders and whales buy or sell their stock.

AKBA Shareholders

What type of owners hold Akebia Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc7.20%19,318,452$22.22MInstitution
Vanguard Group Inc5.97%16,016,448$18.42MInstitution
State Street Corp5.10%13,687,561$15.74MInstitution
Geode Capital Management LLC2.34%6,277,177$7.22MInstitution
Muneer A. Satter1.88%5,039,602$5.80MInsider
Goldman Sachs Group Inc 11.75%4,706,437$5.41MInstitution
Goldman Sachs Group Inc1.75%4,706,437$5.41MInstitution
Citadel Advisors LLC1.74%4,665,537$5.37MInstitution
John P. Butler1.64%4,397,139$5.06MInsider
Renaissance Technologies LLC1.34%3,593,133$4.13MInstitution

1 of 3

AKBA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AKBA44.08%8.14%Net SellingNet Buying
RZLT45.59%54.41%Net BuyingNet Selling
SLN12.77%0.09%
TENX26.24%30.19%Net Buying
ABEO47.38%52.62%Net SellingNet Selling
View Top Biotech Stocks

Akebia Therapeutics Stock Ownership FAQ

Who owns Akebia Therapeutics?

Akebia Therapeutics (NASDAQ: AKBA) is owned by 44.08% institutional shareholders, 8.14% Akebia Therapeutics insiders, and 47.78% retail investors. Muneer A. Satter is the largest individual Akebia Therapeutics shareholder, owning 5.04M shares representing 1.88% of the company. Muneer A. Satter's Akebia Therapeutics shares are currently valued at $5.95M.

If you're new to stock investing, here's how to buy Akebia Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.